Search results
Note: Many side effects of medications may not be reported. Always consult your doctor or healthcare specialist for medical advice. Side effects can be reported to the FDA online at www.fda.gov/safety or call 1-800-FDA-1088 (1-800-332-1088). Search drug side effects. E.g. Benadryl, Warfarin, Lisinopril. Top side effect searches. Adderall.
Tell your doctor right away if you have any serious side effects, including: bone pain, signs of kidney stones (such as severe back/side/abdominal/groin pain, fever, chills, painful/frequent ...
- Addiction, Abuse, and Misuse
- Opioid Analgesic Risk Evaluation and Mitigation Strategy
- Life-Threatening Respiratory Depression
- Neonatal Opioid Withdrawal Syndrome
- Risks from Concomitant Use with Benzodiazepines Or Other CNS Depressants
- Adrenal Insufficiency
- Severe Hypotension
- Risks of Use in Patients with Gastrointestinal Conditions
- Risk of Use in Patients with Seizure Disorders
- Withdrawal
XTAMPZA ER contains oxycodone, a Schedule II controlled substance. As an opioid, XTAMPZA ER exposes users to the risks of addiction, abuse, and misuse [see Drug Abuse And Dependence]. As extended-release products such as XTAMPZA ER deliver the opioid over an extended period of time, there is a greater risk for overdose and death due to the larger a...
To ensure that the benefits of opioid analgesics outweigh the risks of addiction, abuse, and misuse, the Food and Drug Administration (FDA) has required a Risk Evaluation and Mitigation Strategy (REMS) for these products. Under the requirements of the REMS, drug companies with approved opioid analgesic products must make REMS-compliant education pr...
Serious, life-threatening, or fatal respiratory depression has been reported with the use of opioids, even when used as recommended. Respiratory depression, if not immediately recognized and treated, may lead to respiratory arrest and death. Management of respiratory depression may include close observation, supportive measures, and use of opioid a...
Prolonged use of XTAMPZA ER during pregnancy can result in withdrawal in the neonate. Neonatal opioid withdrawal syndrome, unlike opioid withdrawal syndrome in adults, may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts. Observe newborns for signs of neonatal opioid ...
Profound sedation, respiratory depression, coma, and death may result from the concomitant use of XTAMPZA ER with benzodiazepinesor other CNS depressants (e.g., non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, other opioids, alcohol). Because of these risks, reserve concomita...
Cases of adrenal insufficiency have been reported with opioid use, more often following greater than one month of use. Presentation of adrenal insufficiency may include non-specific symptoms and signs including nausea, vomiting, anorexia, fatigue, weakness, dizziness, and low blood pressure. If adrenal insufficiency is suspected, confirm the diagno...
XTAMPZA ER may cause severe hypotension including orthostatic hypotension and syncope in ambulatory patients. There is an increased risk in patients whose ability to maintain blood pressure has already been compromised by a reduced blood volume or concurrent administration of certain CNS depressant drugs (e.g., phenothiazines or general anesthetics...
XTAMPZA ER is contraindicated in patients with gastrointestinal obstruction, including paralytic ileus. The oxycodone in XTAMPZA ER may cause spasm of the sphincter of Oddi. Opioids may cause increases in the serum amylase. Monitor patients with biliary tract disease, including acute pancreatitis, for worsening symptoms.
The oxycodone in XTAMPZA ER may increase the frequency of seizures in patients with seizure disorders, and may increase the risk of seizures in other clinical settings associated with seizures. Monitor patients with a history of seizuredisorders for worsened seizure control during XTAMPZA ER therapy.
Do not abruptly discontinue XTAMPZA ER in a patient physically dependent on opioids. When discontinuing XTAMPZA ER in a physically dependent patient, gradually taper the dosage. Rapid tapering of oxycodone in a patient physically dependent on opioids may lead to a withdrawal syndrome and return of pain [seeDOSAGE AND ADMINISTRATION, Drug Abuse And ...
Jun 27, 2024 · What are the most common side effects of omeprazole? The most common side effects of omeprazole are listed below. Tell your healthcare provider if you have any of these side effects that bother...
Mar 13, 2023 · Topamax, which treats epilepsy and migraine, can cause side effects, such as hair loss and stomach problems. Learn about side effects and dealing with them.
Mar 1, 2024 · Brand names: Cymbalta, Drizalma Sprinkle, Irenka. Dosage form: oral delayed release capsule (20 mg; 30 mg; 40 mg; 60 mg) Drug class: Serotonin-norepinephrine reuptake inhibitors. Medically reviewed by Philip Thornton, DipPharm. Last updated on Mar 1, 2024. Uses. Warnings. Before taking. Dosage. Side effects. Interactions. FAQ. What is duloxetine?
- Consultant Pharmacist
- Common antidepressants used for orthopedic pain relief may include SSRIs like fluoxetine (Prozac), paroxetine (Paxil), and sertraline (Zoloft), SNR...
- Cymbalta is used to treat depression, anxiety, and some pain syndromes. But what are the risks associated with this drug? Do most people who start...
- Not being able to sleep (also called insomnia) is one of the most common side effects reported by people taking Cymbalta. In some people, this side...
- Cymbalta is more likely to cause weight loss early in the first 8 to 9 weeks of treatment, but result in a modest weight gain after 8 months of tre...
- Slowly stopping Cymbalta treatment over 2 to 4 weeks is the best way to help avoid withdrawal symptoms like dizziness, nausea or headache. Talk wit...
- It may take up to 6 to 8 weeks for the full effects of Cymbalta to be seen, although some improvement in symptoms, such as sleep, energy, or appeti...
- People have reported feeling electric shock-like sensations or “brain zaps” when starting Cymbalta (duloxetine) treatment, during treatment, and al...
Index performance for TOPIX Core 30 Index (TPXC30) including value, chart, profile & other market data.
